Association between serum levels and single nucleotide polymorphisms of CXCL10 and thyroid dysfunction in patients with chronic hepatitis C

SHAO Cui-ping,HUO Na,FAN Xiao-hong,ZHENG Ying-ying,BAO Yi,LI Fang,LI Min-ran,LU Hai-ying,XU Xiao-yuan
2013-01-01
Abstract:Objective To investigate the association between serum levels and single nucleotide polymorphisms(SNPs) of CXCL10 and thyroid dysfunction in patients with chronic hepatitis C(CHC) who were untreated with interferon(IFN) α. Methods Of 312 CHC patients untreated with IFN α, 39 were evaluated to have thyroid dysfunction using thyroid function tests(group with thyroid dysfunction), and another 39 matched patients(group without thyroid dysfunction) were selected from the other 273 patients with- out thyroid dysfunction. Serum CXCL10 levels of the two groups were detected by ELISA. Genomic DNA were extracted by QIAamp DNA Blood Mini Kit; CXCL10-135 and CXCL10-1447 fragments were amplified by PCR and sequenced; BioEdit software was used to analyze the sequences. Results Serum CXCL10 levels of patients with and without thyroid dysfunction were 472.11±274.91 pg/ml and 516.39±272.40 pg/ml, respectively, and the difference between the two groups was not statistically significant. Frequen- cies of G and T alleles of CXCL10-135 were 95.0% and 5.0% in patients with thyroid dysfunction, and were 96.2% and 3.8% in patients without thyroid dysfunction, and the differences between the two groups were not statistically significant. Frequencies of A and G alleles of CXCL10-1447 were 41.7% and 58.3% in patients with thyroid dysfunction, and were 47.4% and 52.6% in patients without thyroid dysfunction, and the differences between the two groups were not statistically significant. Frequencies of GG, GT and TT genotypes of CXCL10-135 were 93.4%, 3.3% and 3.3% in patients with thyroid dysfunction, and were 92.3%, 7.7% and 0% in patients without thyroid dysfunction, and the differences between the two groups were not statistically significant. Frequencies of AA, AG and GG genotypes of CXCL10-1447 were 16.7%, 50.0% and 33.3% in patients with thyroid dysfunction, and were 20.5%, 53.9% and 25.6% in patients without thyroid dysfunction, and the differences between the two groups were not statistically sig- nificant. Conclusion Thyroid dysfunction in CHC patients untreated with IFN α is not associated with serum levels and-135 and-1447 SNPs of CXCL10.
What problem does this paper attempt to address?